EUA
Infinity BiologiX TaqPath SARS-CoV-2 Assay
FDA Emergency Use Authorization · Infinity BiologiX LLC · Aug 18, 2021
Key facts
| Product | Infinity BiologiX TaqPath SARS-CoV-2 Assay |
|---|---|
| Company | Infinity BiologiX LLC |
| Product type | Real-time RT-PCR, Home Collection, Saliva, Pooling, Multiple Targets |
| Date | Aug 18, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: